These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 6458120

  • 21. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
    Doolittle RF, Pandi L.
    Biochemistry; 2006 Feb 28; 45(8):2657-67. PubMed ID: 16489759
    [Abstract] [Full Text] [Related]

  • 22. Plasmin, plasmin inhibitors, and degradation products of fibrinogen in human serum during and after intravenous infusion of streptokinase.
    Nilsson IM.
    J Clin Pathol; 1969 May 28; 22(3):371. PubMed ID: 4239466
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasmin.
    Edelberg JM, Pizzo SV.
    Biochem J; 1992 Aug 15; 286 ( Pt 1)(Pt 1):79-84. PubMed ID: 1381585
    [Abstract] [Full Text] [Related]

  • 30. Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test.
    Hawiger J, Niewiarowski S, Gurewich V, Thomas DP.
    J Lab Clin Med; 1970 Jan 15; 75(1):93-108. PubMed ID: 4243578
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The evaluation of plasmin and streptokinase activator complexes in a new rabbit model of venous thrombosis.
    Dupe RJ, English PD, Smith RA, Green J.
    Thromb Haemost; 1981 Aug 28; 46(2):528-34. PubMed ID: 6458112
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The inhibitory effect of plasma inhibitor on plasmin activated with streptokinase or urokinase.
    Sumi H, Takada Y, Takada A.
    Nihon Seirigaku Zasshi; 1977 Aug 28; 39(5):112-4. PubMed ID: 72149
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor.
    Sakata Y, Aoki N.
    J Clin Invest; 1980 Feb 28; 65(2):290-7. PubMed ID: 6444305
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. In vitro preparation of nonenzymatically glucosylated human transferrin, alpha 2-macroglobulin, and fibrinogen with preservation of function.
    Ney KA, Pasqua JJ, Colley KJ, Guthrow CE, Pizzo SV.
    Diabetes; 1985 May 28; 34(5):462-70. PubMed ID: 2580749
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.